Bryan Eric Strauss
Impact in
- Genetics top 5%
- Virus-based gene therapy research
- Mesenchymal stem cell research
- Immunology top 5%
- Immunotherapy and Immune Responses
Papers in
- Co-authors
- Marcio Chaim Bajgelman (14 shared papers)Mayana Zatz (3 shared papers)Aline Hunger (14 shared papers)Martin Haas (4 shared papers)Eder Zucconi (2 shared papers)Natássia M. Vieira (2 shared papers)Ruan F.V. Medrano (9 shared papers)Vanessa Brandalise (2 shared papers)
- Journals
- Brazilian Journal of Medical and Biological Research (6 papers)Biochemical and Biophysical Research Communications (4 papers)Virology (4 papers)Blood (3 papers)Cancers (3 papers)
- Partner nations
- BrazilUnited StatesFrance
In The Last Decade
Bryan Eric Strauss
81 papers receiving 2.6k citations
Bryan Eric Strauss's Hit Papers
Peers
Comparison fields: 5 of 104
- Genetics 360
- Immunology 690
- Oncology 821
- Biotechnology 157
- Cancer Research 230
Countries citing papers authored by Bryan Eric Strauss
This map shows the geographic impact of Bryan Eric Strauss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bryan Eric Strauss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bryan Eric Strauss more than expected).
Fields of papers citing papers by Bryan Eric Strauss
This network shows the impact of papers produced by Bryan Eric Strauss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bryan Eric Strauss. The network helps show where Bryan Eric Strauss may publish in the future.
Co-authors
The 25 scholars most cited alongside Bryan Eric Strauss, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Consensus guidelines for the definition, detection and interpretation of immunogenic cell death Hit paper breakdown → | 2020 | 897 |
| 2 | 2010 | 215 | |
| 3 | 2017 | 141 | |
| 4 | Repression of the insulin receptor promoter by the tumor suppressor gene product p53: a possible mechanism for receptor overexpression in breast cancer. | 1996 | 136 |
| 5 | 2008 | 86 | |
| 6 | 2011 | 56 | |
| 7 | 2015 | 52 | |
| 8 | 2013 | 48 | |
| 9 | 2010 | 46 | |
| 10 | 2016 | 42 | |
| 11 | 2007 | 40 | |
| 12 | 1997 | 36 | |
| 13 | 1998 | 35 | |
| 14 | 2010 | 29 | |
| 15 | 2019 | 27 | |
| 16 | 2003 | 27 | |
| 17 | 2006 | 27 | |
| 18 | 2017 | 27 | |
| 19 | 2017 | 27 | |
| 20 | 1995 | 24 |
About Bryan Eric Strauss
Bryan Eric Strauss is a scholar working on Genetics, Oncology, Immunology, Molecular Biology and Biotechnology, having authored 84 papers that have together received 2.7k indexed citations. Recurring topics across this work include Virus-based gene therapy research (34 papers), RNA Interference and Gene Delivery (21 papers), Cancer-related Molecular Pathways (16 papers), CAR-T cell therapy research (11 papers), Cancer Research and Treatments (9 papers), Immunotherapy and Immune Responses (9 papers), CRISPR and Genetic Engineering (8 papers) and interferon and immune responses (8 papers). The work is most often cited by research in Genetics (360 citations), Immunology (690 citations), Oncology (821 citations), Biotechnology (157 citations) and Cancer Research (230 citations). Bryan Eric Strauss has collaborated with scholars based in Brazil, United States and France. Frequent co-authors include Marcio Chaim Bajgelman, Mayana Zatz, Aline Hunger, Martin Haas, Eder Zucconi, Natássia M. Vieira, Ruan F.V. Medrano, Vanessa Brandalise, Samir Andrade Mendonça and José Alexandre Marzagão Barbuto. Their work appears in journals such as Brazilian Journal of Medical and Biological Research, Biochemical and Biophysical Research Communications, Virology, Blood and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.